Skeletal Abnormalities in Lysosomal Storage Diseases

被引:1
作者
Stevenson, David A. [1 ]
Steiner, Robert D. [2 ]
机构
[1] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA
[2] Marshfield Clin Fdn Med Res & Educ, Res Fdn, Marshfield, WI USA
关键词
bone; lysosomal storage diseases; mucopolysaccharidosis; skeletal; ENZYME-REPLACEMENT THERAPY; BONE-MARROW-TRANSPLANTATION; TERM-FOLLOW-UP; GAUCHER-DISEASE; MUCOPOLYSACCHARIDOSIS-VI; POMPE-DISEASE; BETA-MANNOSIDOSIS; MURINE MODEL; MOUSE MODEL; CELL TRANSPLANTATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many of the lysosomal storage diseases (LSDs) have skeletal abnormalities causing significant morbidity. Dysostosis multiplex describes a constellation of radiographic skeletal findings that are helpful in diagnosing many of the LSDs, particularly the mucopolysaccharidoses (MPS). This review discusses the clinical and radiographic skeletal manifestations of various LSDs with an emphasis on disorders that have significant skeletal involvement (eg, MPS disorders, mucolipidosis type II and Iil, Gaucher). Enzyme replacement therapy (ERT) for several of the LSDs has been beneficial for many of the clinical manifestations, but efficacy with regard to the skeletal abnormalities is not as obvious. As the pathophysiology of the skeletal abnormalities associated with LSDs becomes better elucidated, investigators will likely develop improved therapies to specifically target bone and alleviate the skeletal problems.
引用
收藏
页码:406 / 416
页数:11
相关论文
共 110 条
[1]   Musculoskeletal manifestations of lysosomal storage disorders [J].
Aldenhoven, M. ;
Sakkers, R. J. B. ;
Boelens, J. ;
de Koning, T. J. ;
Wulffraat, N. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) :1659-1665
[2]   Chondroitin sulfate and growth factor signaling in the skeleton: Possible links to MPS VI [J].
Alliston, Tamara .
JOURNAL OF PEDIATRIC REHABILITATION MEDICINE, 2010, 3 (02) :129-138
[3]   Bone marrow transplantation for aspartylglucosaminuria: Follow-up study of transplanted and non-transplanted patients [J].
Arvio, M ;
Sauna-aho, O ;
Peippo, M .
JOURNAL OF PEDIATRICS, 2001, 138 (02) :288-290
[4]   An overview of intra-articular therapy for mucopolysaccharidosis VI [J].
Auclair, Dyane ;
Ketteridge, David ;
Oates, Stephanie ;
Hopwood, John J. ;
Byers, Sharon .
JOURNAL OF PEDIATRIC REHABILITATION MEDICINE, 2010, 3 (01) :3-6
[5]   Variable clinical presentation of lysosomal β-mannosidosis in patients with null mutations [J].
Bedilu, R ;
Nummy, KA ;
Cooper, A ;
Wevers, R ;
Smeitink, J ;
Kleijer, WJ ;
Friderici, KH .
MOLECULAR GENETICS AND METABOLISM, 2002, 77 (04) :282-290
[6]   Infrared imaging microscopy of bone: Illustrations from a mouse model of Fabry disease [J].
Boskey, Adele L. ;
Goldberg, Michel ;
Kulkarni, Ashok ;
Gomez, Santiago .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (07) :942-947
[7]  
Bruni S, 2007, Acta Myol, V26, P87
[8]   Fractures in children with Pompe disease: a potentiallong-term complication [J].
Case, Laura E. ;
Hanna, Rabi ;
Frush, Donald P. ;
Krishnamurthy, Vidya ;
DeArmey, Stephanie ;
Mackey, Joanne ;
Boney, Anne ;
Morgan, Claire ;
Corzo, Deyanira ;
Bouchard, Susan ;
Weber, Thomas J. ;
Chen, Yuan-Tsong ;
Kishnani, Priya S. .
PEDIATRIC RADIOLOGY, 2007, 37 (05) :437-445
[9]   Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence [J].
Chen, Wei ;
Yang, Shuying ;
Abe, Yoke ;
Li, Ming ;
Wang, Yucheng ;
Shao, Jianzhong ;
Li, En ;
Li, Yi-Ping .
HUMAN MOLECULAR GENETICS, 2007, 16 (04) :410-423
[10]   Short-term effects of pamidronate in patients with Gaucher's disease and severe skeletal involvement [J].
Ciana, G ;
Cuttini, M ;
Bembi, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) :712-712